Condition
Hepatitis B Vaccine Adverse Reaction
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Unknown1
Withdrawn1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05482282Phase 3Withdrawn
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
NCT06023056Recruiting
Hepatitis B Vaccination After Neonatal Surgery
NCT03867643UnknownPrimary
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
Showing all 3 trials